A carregar...
Characteristics and clinical trial results of agonistic anti-CD40 antibodies in the treatment of malignancies
Cluster of differentiation 40 (CD40) mediates many immune activities. Preclinical studies have shown that activation of CD40 can evoke massive antineoplastic effects in several tumour models in vivo, providing a rationale for using CD40 agonists in cancer immunotherapy. To date, several potential ag...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7471753/ https://ncbi.nlm.nih.gov/pubmed/32934743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12037 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|